# Vertex Pharmaceuticals (VRTX) P/S ratio: 11.5× today

URL: https://funkfolio.com/stock/VRTX/ps-ratio

> Vertex Pharmaceuticals (VRTX) P/S ratio is 11.5× today, against 9.7× at the end of fiscal 2025. Its median over 18 fiscal year-ends is 12.2×.

---

## Vertex Pharmaceuticals (VRTX) P/S ratio

**P/S ratio today:** 11.5× as of Nov 18, 2026, 9:40 AM UTC

Vertex Pharmaceuticals (VRTX) trades at 11.5× its revenue per share for fiscal 2025. At the end of fiscal 2025 (December 31, 2025) its P/S ratio was 9.7×. That is 3.4% higher than the 9.4× of fiscal 2024. Figures as of 18 Nov 2026, 09:40 UTC, from the company's filings with the SEC and Yahoo Finance.

### Key facts

- **P/S ratio today:** 11.5×
- **P/S ratio, fiscal 2025:** 9.7×
- **Change on fiscal 2024:** +3.4%
- **Highest on record:** 72.9× fiscal 2009
- **Lowest on record:** 4.9× fiscal 2011
- **Fiscal years on record:** 18 2008–2025

Figures as of 18 Nov 2026, 09:40 UTC. Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

### Vertex Pharmaceuticals P/S ratio, in more detail

Today's figure is 17.8% above the fiscal 2025 year-end.

Across the 18 fiscal year-ends on record (2008–2025), the highest was 72.9× in fiscal 2009 and the lowest 4.9× in fiscal 2011. Today's P/S ratio is higher than at 50% of the 18 fiscal year-ends on record; their median is 12.2×.

### P/S ratio at each fiscal year-end

The last point is today's figure; the others are fiscal year-ends.

### Vertex Pharmaceuticals P/S ratio, year by year

Vertex Pharmaceuticals (VRTX) P/S ratio by fiscal year

| Fiscal year | P/S ratio | Change | Year ended | Share price at year-end | Revenue per share |
| --- | --- | --- | --- | --- | --- |
| Today | 11.5× | — | Nov 18, 2026 | $534.20 | — |
| 2025 | 9.7× | 3.4% up | Dec 31, 2025 | $453.36 | $46.52 |
| 2024 | 9.4× | 12.3% down | Dec 31, 2024 | $402.70 | $42.73 |
| 2023 | 10.7× | 28.2% up | Dec 31, 2023 | $406.89 | $37.89 |
| 2022 | 8.4× | 11.2% up | Dec 31, 2022 | $288.78 | $34.47 |
| 2021 | 7.5× | 24.9% down | Dec 31, 2021 | $219.60 | $29.14 |
| 2020 | 10.0× | 26.8% down | Dec 31, 2020 | $236.34 | $23.56 |
| 2019 | 13.7× | 2.7% down | Dec 31, 2019 | $218.95 | $15.97 |
| 2018 | 14.1× | 7.6% down | Dec 31, 2018 | $165.71 | $11.76 |
| 2017 | 15.2× | 44.0% up | Dec 31, 2017 | $149.86 | $9.83 |
| 2016 | 10.6× | 64.0% down | Dec 31, 2016 | $73.67 | $6.96 |
| 2015 | 29.4× | 38.9% down | Dec 31, 2015 | $125.83 | $4.28 |
| 2014 | 48.2× | 249.3% up | Dec 31, 2014 | $118.80 | $2.47 |
| 2013 | 13.8× | 133.4% up | Dec 31, 2013 | $74.30 | $5.39 |
| 2012 | 5.9× | 20.2% up | Dec 31, 2012 | $41.90 | $7.09 |
| 2011 | 4.9× | 90.0% down | Dec 31, 2011 | $33.21 | $6.76 |
| 2010 | 49.0× | 32.8% down | Dec 31, 2010 | $35.03 | $0.72 |
| 2009 | 72.9× | 199.5% up | Dec 31, 2009 | $42.85 | $0.59 |
| 2008 | 24.3× | — | Dec 31, 2008 | $30.38 | $1.25 |

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

### How it is calculated

The P/S ratio is the share price divided by revenue per share — the same thing as market value divided by revenue — taken at each fiscal year-end.

### How to read it

It prices each unit of sales and still works when there is no profit; what counts as high depends on the margin those sales earn.

### P/S ratio at health care companies of similar size

P/S ratio of Vertex Pharmaceuticals and comparable companies

| Company | P/S ratio |
| --- | --- |
| [Pfizer PFE](https://funkfolio.com/stock/PFE/ps-ratio) | 2.6× |
| [Danaher DHR](https://funkfolio.com/stock/DHR/ps-ratio) | 6.5× |
| [Intuitive Surgical ISRG](https://funkfolio.com/stock/ISRG/ps-ratio) | 14.8× |
| Vertex Pharmaceuticals VRTX | 11.3× |
| [Medtronic MDT](https://funkfolio.com/stock/MDT/ps-ratio) | 3.6× |
| [Bristol-Myers Squibb BMY](https://funkfolio.com/stock/BMY/ps-ratio) | 2.6× |

Today's market value divided by revenue for the latest fiscal year. A company whose statements are in another currency than its shares is left out.

### Vertex Pharmaceuticals, figure by figure

- [Vertex Pharmaceuticals market cap](https://funkfolio.com/stock/VRTX/market-cap)
- [Vertex Pharmaceuticals revenue](https://funkfolio.com/stock/VRTX/revenue)
- [Vertex Pharmaceuticals earnings](https://funkfolio.com/stock/VRTX/earnings)
- [Vertex Pharmaceuticals earnings per share (EPS)](https://funkfolio.com/stock/VRTX/eps)
- [Vertex Pharmaceuticals P/E ratio](https://funkfolio.com/stock/VRTX/pe-ratio)
- [Vertex Pharmaceuticals P/B ratio](https://funkfolio.com/stock/VRTX/pb-ratio)
- [Vertex Pharmaceuticals free cash flow](https://funkfolio.com/stock/VRTX/free-cash-flow)
- [Vertex Pharmaceuticals operating margin](https://funkfolio.com/stock/VRTX/operating-margin)
- [Vertex Pharmaceuticals dividend](https://funkfolio.com/stock/VRTX/dividend)
- [Vertex Pharmaceuticals shares outstanding](https://funkfolio.com/stock/VRTX/shares-outstanding)
- [Vertex Pharmaceuticals total debt](https://funkfolio.com/stock/VRTX/total-debt)
- [Vertex Pharmaceuticals cash on hand](https://funkfolio.com/stock/VRTX/cash)
- [Vertex Pharmaceuticals total assets](https://funkfolio.com/stock/VRTX/total-assets)
- [Vertex Pharmaceuticals return on equity (ROE)](https://funkfolio.com/stock/VRTX/roe)
- [Vertex Pharmaceuticals return on invested capital (ROIC)](https://funkfolio.com/stock/VRTX/roic)

[Vertex Pharmaceuticals (VRTX) overview: price, valuation and scorecard](https://funkfolio.com/stock/VRTX) [All health care companies by market value](https://funkfolio.com/companies/sector/health-care)

### Vertex Pharmaceuticals P/S ratio: questions and answers

**What is Vertex Pharmaceuticals's P/S ratio?**

Vertex Pharmaceuticals (VRTX) trades at 11.5× its revenue per share for fiscal 2025. At the end of fiscal 2025 (December 31, 2025) its P/S ratio was 9.7×. That is 3.4% higher than the 9.4× of fiscal 2024.

**Is Vertex Pharmaceuticals's P/S ratio high or low compared with its own history?**

Today's P/S ratio is higher than at 50% of the 18 fiscal year-ends on record; their median is 12.2×.

**What are the highest and lowest P/S ratio figures on record for Vertex Pharmaceuticals?**

Across the 18 fiscal year-ends on record (2008–2025), the highest was 72.9× in fiscal 2009 and the lowest 4.9× in fiscal 2011.

**How is Vertex Pharmaceuticals's P/S ratio calculated?**

The P/S ratio is the share price divided by revenue per share — the same thing as market value divided by revenue — taken at each fiscal year-end. For Vertex Pharmaceuticals it is on record here for 18 fiscal years, 2008 to 2025.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

### Learn: P/S ratio

[All stocks guides →](https://funkfolio.com/learn/stocks)

- [P/E ratio explained: what a high or low figure means](https://funkfolio.com/learn/stocks/pe-ratio)

  The price-to-earnings (P/E) ratio is a share's price divided by its earnings per share. A stock at $100 earning $5 a share has a P/E of 20: buyers pay $20 for each dollar of yearly profit. A high P/E usually means the market expects profit to grow; a low one can mean doubt, not a bargain.
- [Revenue vs earnings vs free cash flow: what each tells you](https://funkfolio.com/learn/stocks/revenue-earnings-free-cash-flow)

  Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- [Altman Z-score: formula, zones and where it fails](https://funkfolio.com/learn/stocks/altman-z-score)

  The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.

### Cite this page

Funkfolio, “Vertex Pharmaceuticals (VRTX) P/S ratio”, data as of 18 November 2026. https://funkfolio.com/stock/VRTX/ps-ratio

Underlying data: the company's filings with the SEC and Yahoo Finance.
